Inside Story

Will the world’s first malaria vaccine eradicate the disease?

WHO approves the first jab against malaria for widespread use among children in Africa.

With the world focused on COVID-19 vaccines, a breakthrough has been made in the fight against another disease.

The World Health Organization (WHO) has approved a malaria vaccine for widespread use among children in Africa.

It follows decades of development and successful trials in Ghana, Kenya and Malawi.

The WHO and drugmaker GlaxoSmithKline say it is a breakthrough.

Could it help eradicate the disease? And will it be affordable for those who need it most?

Presenter: Kamahl Santamaria


Akpaka Kalu – WHO regional adviser for tropical and vector-borne diseases

Helen Rees – Board member, Gavi, the Vaccine Alliance

Abdhalah Ziraba – Research scientist, African Population and Health Research Center